| # | Drug | Count |
|---|---|---|
| 0 | RILPIVIRINE HYDROCHLORIDE | 20 |
| 1 | LAMOTRIGINE | 14 |
| 2 | CLOBAZAM | 10 |
| 3 | LEVETIRACETAM | 9 |
| 4 | ATAZANAVIR | 8 |
| 5 | LAMIVUDINE AND ZIDOVUDINE | 8 |
| 6 | RITONAVIR | 8 |
| 7 | ALPRAZOLAM | 7 |
| 8 | FOLIC ACID | 7 |
| 9 | LAMOTIRIGINE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAMIVUDINE AND ZIDOVUDINE | 8 | 0.0010 |
| 1 | CLOBAZAM | 10 | 0.0006 |
| 2 | ATAZANAVIR | 8 | 0.0006 |
| 3 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 2 | 0.0006 |
| 4 | ESTAZOLAM | 1 | 0.0005 |
| 5 | MARAVIROC | 1 | 0.0004 |
| 6 | CABOTEGRAVIR AND RILPIVIRINE | 2 | 0.0003 |
| 7 | DARUNAVIR | 4 | 0.0003 |
| 8 | ETRAVIRINE | 1 | 0.0002 |
| 9 | BELIMUMAB | 6 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 1 | Protease Inhibitor [EPC] | 10 | 0.0002 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0002 |
| 3 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 6 | 0.0002 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 11 | 0.0002 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 17 | 0.0002 |
| 7 | Vitamin K [EPC] | 1 | 0.0001 |
| 8 | Mood Stabilizer [EPC] | 20 | 0.0001 |
| 9 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |